• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

Professional Introduction to 2',5'-Dibromo-3'-fluoroacetophenone (CAS No. 1803715-96-9)

2',5'-Dibromo-3'-fluoroacetophenone (CAS No. 1803715-96-9) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research due to its unique structural and chemical properties. This compound, featuring both bromine and fluorine substituents on a benzene ring with an acetophenone moiety, exhibits promising characteristics for further derivatization and application in synthetic chemistry.

The molecular structure of 2',5'-Dibromo-3'-fluoroacetophenone consists of a phenyl ring substituted at the 2' and 5' positions with bromine atoms, while the 3' position is functionalized with a fluoroacetyl group. This arrangement provides a versatile platform for further chemical modifications, making it a valuable intermediate in the synthesis of more complex molecules. The presence of both bromine and fluorine atoms enhances its reactivity, enabling various cross-coupling reactions, nucleophilic substitutions, and other transformations that are critical in modern drug discovery.

In recent years, 2',5'-Dibromo-3'-fluoroacetophenone has been explored in the development of novel pharmaceutical agents. Its structural features are particularly relevant in the synthesis of bioactive molecules targeting specific biological pathways. For instance, studies have demonstrated its utility in generating fluorinated aromatic compounds, which are known to improve metabolic stability and binding affinity in drug candidates. The fluorine atom, in particular, is widely recognized for its ability to modulate pharmacokinetic properties, making it a key element in medicinal chemistry.

One of the most notable applications of 2',5'-Dibromo-3'-fluoroacetophenone is in the synthesis of kinase inhibitors, which play a crucial role in treating various cancers and inflammatory diseases. The brominated aromatic core allows for easy incorporation into libraries of small molecules for high-throughput screening (HTS). Researchers have leveraged this compound to develop inhibitors targeting tyrosine kinases, where the combination of bromine and fluorine substituents enhances selectivity and potency. Preliminary findings suggest that derivatives of 2',5'-Dibromo-3'-fluoroacetophenone exhibit promising inhibitory activity against mutant forms of kinases associated with drug resistance.

Furthermore, 2',5'-Dibromo-3'-fluoroacetophenone has been utilized in the synthesis of agrochemicals, where its structural motifs contribute to the development of novel pesticides with improved efficacy and environmental safety. The halogenated aromatic system provides a scaffold for designing compounds that interact selectively with biological targets in pests while minimizing toxicity to non-target organisms. This aligns with the growing demand for sustainable agricultural practices that reduce reliance on traditional chemical formulations.

The synthetic utility of 2',5'-Dibromo-3'-fluoroacetophenone extends beyond pharmaceuticals and agrochemicals. It serves as a key intermediate in materials science, particularly in the development of organic electronic materials such as OLEDs (organic light-emitting diodes) and semiconductors. The presence of electron-withdrawing groups like the fluoroacetyl moiety influences electronic properties, making it valuable for tuning charge transport characteristics in these applications.

Recent advances in computational chemistry have further highlighted the potential of 2',5'-Dibromo-3'-fluoroacetophenone as a building block for drug discovery. Molecular modeling studies indicate that its scaffold can be modified to enhance binding interactions with protein targets through hydrogen bonding networks and hydrophobic clustering. These insights have guided experimental efforts to optimize derivatives for therapeutic applications.

The preparation of 2',5'-Dibromo-3'-fluoroacetophenone typically involves multi-step synthetic routes starting from commercially available precursors such as acetophenone or bromobenzene derivatives. Fluorination reactions are often performed using electrophilic or nucleophilic strategies, depending on the desired regioselectivity. The integration of green chemistry principles into these synthetic processes has also been explored to minimize waste and improve atom economy.

In conclusion, 2',5'-Dibromo-3'-fluoroacetophenone (CAS No. 1803715-96-9) represents a versatile intermediate with broad applicability across multiple scientific disciplines. Its unique structural features make it an invaluable tool for researchers engaged in medicinal chemistry, agrochemical innovation, and materials science. As our understanding of its reactivity and potential continues to evolve, this compound is poised to play an even greater role in advancing technological and medical breakthroughs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)